$DOCUNeutralMed

DocuSign’s (NASDAQ:DOCU) Q1 CY2026 Sales Top Estimates

DocuSign reported Q1 CY2026 revenue of $830.2 million, up 8.7% year on year and 0.6% above analysts’ estimates, according to the company. Non-GAAP EPS was $1.09, 9.7% above consensus. DocuSign guided Q2 revenue to about $867 million.

9/10
8/10
Med
Neutral
after-hours/after-report reaction (stock down 1.7% immediately after reporting)
mixed (beat/guidance supportive, but efficiency and deceleration concerns weigh)

Beat-and-guidance print but with decelerating growth and negative CAC payback, implying mixed demand/efficiency signals for DOCU.

DocuSign reported Q1 CY2026 revenue $830.2M (+8.7% YoY) above estimates and guided next-quarter revenue near $867M.

Near-term volatility likely; upside depends on whether AI-native IAM demand offsets slowing growth and CAC inefficiency.

Background

The piece frames DocuSign’s Q1 CY2026 results versus prior growth trends and highlights AI-native IAM demand alongside customer acquisition efficiency.

Why it matters

DOCU’s upside case rests on AI-native IAM momentum and a near-consensus revenue guide; the downside case is decelerating growth and negative CAC payback suggesting weaker incremental economics.

Market relevance

A fresh earnings/guidance datapoint for DOCU with immediate post-report price reaction and explicit efficiency concerns (negative CAC payback).

Market effects

Signals ongoing demand/monetization pressure in enterprise software/e-signature, where growth deceleration and sales-efficiency metrics matter.

No specific regional catalyst mentioned; primarily US-listed software sentiment.

DocuSign serves global users, but the article provides no region-specific drivers beyond company-wide results.

Alternative perspectives

The revenue beat plus AI-native IAM customer growth (40,000 customers) could indicate the market is overreacting to CAC payback noise.

CAC payback being negative this quarter may reflect timing of marketing spend or customer ramp; the article doesn’t break out cohort retention or margin trajectory beyond non-GAAP EPS.

Key entities

  • DocuSign

    Electronic signature and agreement management platform reporting Q1 CY2026 revenue beat and next-quarter guidance.

  • Allan Thygesen

    CEO quoted attributing demand strength to DocuSign’s AI-native IAM platform.

Related articles

$LULUMed

Stock Market Today: Dow Futures Gain, S&P 500 Slips As Trump Floats Meeting Iran's Supreme Leader— Lulule

U.S. stock futures were mixed Friday: Nasdaq 100 and S&P 500 slipped while Dow futures rose after a mixed prior close. President Trump said he would consider meeting Iran’s Supreme Leader Ayatollah Mojtaba Khamenei if diplomacy progresses. Treasury yields were 4.46% (10-year) and 4.03% (2-year); FedWatch priced a 96.4% chance of no June rate change. Lululemon, Docusign (-4.73%), Samsara (-5.14%), and Keel (-8.94% on $350m convertibles) were among movers.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.

$DOCUMedAI 9/10

DocuSign Delivers Beat-And-Raise Q1, But Investors Aren't Impressed - Docusign (NASDAQ:DOCU)

DocuSign reported Q1 revenue of $830.2 million, slightly above the $824.77 million consensus, and adjusted EPS of $1.09 versus $0.99 expected, according to Benzinga Pro. Revenue rose 9% YoY; free cash flow was $289.4 million. The company repurchased $317.5 million of stock and raised FY revenue guidance to $3.49–$3.502 billion. Shares were down 4.02% after hours to $48.85.

$DOCUMedAI 9/10

DocuSign (DOCU) Q1 Earnings Report Preview: What To Look For

DocuSign will report Q1 results Thursday after the bell, according to the article. The company’s prior quarter revenue was $836.9 million (+7.8% YoY), but it missed annual recurring revenue estimates. For Q1, analysts expect revenue +8.1% YoY. The article cites an average analyst price target of $59.88 vs. $55.18.

$DOCULowAI 9/10

Dear Docusign Stock Fans, Mark Your Calendars for June 4

DocuSign shares have fallen 36.58% over 52 weeks and 17.84% YTD, but rose 24.69% over three months and 17.18% in the past month, ahead of earnings. After Q4 FY2026 results on March 17, revenue rose 7.8% YoY to $836.9M (above $828.2M est.); non-GAAP EPS was $1.01 (vs $0.95). Billings exceeded $1B for the first time. Q1 FY2027 revenue guidance: $822M–$826M. Analysts rate DOCU “Hold” with $58.81 average target.